Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of peramivir inhalation solution for uncomplicated influenza in adults
CTR20233494Phase 2Completed
- Sponsor
- Nanxin Pharmaceutical
- Start
- Nov 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of peramivir in Influenza A infection, influenza B, influenza, sponsored by Nanxin Pharmaceutical. Started Nov 2023; status: completed.
02
Drugs
peramivir
03
Conditions
Influenza A infectioninfluenza Binfluenza
Beyond the preview
Go deeper on CTR20233494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233494.